Status: Recruiting
An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)
An open-label single center, proof of concept study evaluating the efficacy of Roflumilast foam 0.3% in pediatric subjects with Non-Segmental Vitiligo (NSV)
Participants needed: 20
Trial details
Phase: Phase 2Age: 2-18Biological sex: AllType: InterventionalSponsor: Derm Texas, PLLCUpdated: Aug 8, 2025Locations: 1
Eligibility criteria
Male or female subjects aged 2 years but less than 18 years [+7]
Subjects with any serious medical condition or physical examination abnormality... [+13]